This Solicitation opportunity from Department Of Defense was posted on August 26, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

DEXTROSE INJECTION

Closed

SPE2DP-26-T-4667Federal

Submission Closed08/28/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

BENZOCAINE ORAL TOPICA

Solicitation # SPE2DP-27-T-0076

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0079

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

PERMETHRIN CREAM RINSE

Solicitation # SPE2DP-27-T-0080

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0077

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0081

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Radiopharmaceutical Cold Kit and Unit Dose SupplierThis subcontract involves the manufacture and supply of radiopharmaceutical kits and unit doses to support prime contractors on Department of Veterans Affairs nuclear medicine projects. The scope of work includes providing Cold Kits such as MAA, MDP, Mebrofenin, and PYP, as well as Tc99m, I-123, and In-111 variants. Additionally, the supplier must provide bar-labeled inserts that are compatible with the PineStar Nuclear Medicine Information Management System, with all deliveries directed to secure location room 3A101B. To qualify for this contract, the provider must maintain a valid NRC license and accreditation while ensuring full compliance with DOT, NHPP, FDA, and OSHA regulations. Managed by the Department of Veterans Affairs Network Contract Office 4, the project falls under NAICS code 325412 and is centered in the 19104 zip code area.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

6505--Lab Supplies - Radiopharm Philadelphia VA Medical Center

Solicitation # 36C24427Q0018

The Department of Veterans Affairs, Network Contracting Office 4, is soliciting quotations for an indefinite-quantity contract to provide essential radiopharmaceuticals and calibration sources for the Corporal Michael J. Crescenz VA Medical Center Nuclear Medicine Department. The contract covers a five-year period of performance from November 1, 2026, to October 31, 2031, consisting of a base year and four option years. The selected vendor must be licensed and accredited by the Nuclear Regulatory Commission and comply with all regulations from the DOT, NHPP, FDA, and OSHA. Deliveries are to be made to a secure location at the medical center, with routine orders due by 8:00 AM the following workday and same-day deliveries required within two hours of order placement during normal business hours. The scope of work includes the supply of various radiopharmaceutical kits and calibration sources, such as Co57 and Tc99m variants. Contractors must ensure all radioactive materials are clearly labeled with proper class and exposure levels, and unit doses must include preparation and expiration details. Additionally, the vendor must provide bar-labeled inserts compatible with the PineStar Nuclear Medicine Information Management System or provide a compatible system, including data migration and training, at no additional cost. Award will be based on a comparative evaluation of price and past performance, with a preference for HUBZone Small Business Concerns. Quotations must be submitted electronically to the Contracting Officer in two parts: a price quotation and past performance information from the last three years. Invoicing is to be handled monthly and submitted electronically via the Austin Payment Center.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program

Solicitation # HT9402-26-Q-9404

Defense Health Agency (dha)

POSTED

DEADLINE

Solicitation # HT940827Q0002

The Defense Health Agency intends to award a sole source contract to INO Therapeutics LLC for the procurement and delivery of Inhaled Nitric Oxide for the Department of Medicine at Brooke Army Medical Center in Fort Sam Houston, Texas. The contract covers a base period from January 1, 2027, to December 31, 2027, with four additional option years. The scope of work includes the supply of 800 PPM nitric oxide for inhalation, a specialized delivery device, all necessary maintenance and calibration accessories, and comprehensive support services such as training and logistics. This notice serves as a sources-sought inquiry to determine if other capable vendors exist before finalizing the sole source award. Interested parties must submit written evidence of their capability to meet all technical requirements to Contracting Officer Joe D. Wells by October 22, 2026, at 12:00 PM CST. Submissions must demonstrate that competition would be beneficial to the government without being cost or schedule prohibitive.

Defense Health Agency

POSTED

DEADLINE

Blood Cell Staining Kit SupplierThis subcontract involves the supply of specialized Blood Cell Staining Kits for prime contractors supporting Department of Defense projects under the DLA Troop Support Medical Supply Chain. The required kits must feature Wright's stain compatible with Ames Hematek slide stainers, utilizing Romanowski type modified polychrome methylene blue or thiazine and xanthine dyes. All products must adhere to MIL-STD-2073-1E and Medical Marking Standard No. 1. Key operational requirements include a strict manufacture-to-delivery timeline of one month and a minimum shelf life of 12 months. The contract specifies the delivery of one kit on a FOB Destination basis to a performance location in FPO 09566-4008. The opportunity is categorized under NAICS code 325412.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Dextrose Injection SupplierThis subcontract involves the supply of 3,328 units of FDA-regulated Dextrose Injection 5%, 100 ML for prime contractors supporting Department of Defense DLA Troop Support Medical Supply Chain projects. The selected supplier must manufacture or source the product from FDA-approved facilities, ensuring a minimum shelf life of 24 months and strict adherence to Medical Marking Standard No. 1 and MIL-STD-2073-1E. The agreement requires full compliance with the Buy American Act and the Berry Amendment, with delivery terms set as FOB Destination to APO 09227-0000. This procurement falls under NAICS code 325412 and is managed by the Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Heparin Sodium Injection, USP SupplierThis subcontract involves the supply of FDA-regulated Heparin Sodium Injection, USP, to prime contractors supporting Department of Defense supply contracts through the Medical Supply Chain Pharm FSA. The scope of work requires the manufacture or distribution of 5000 unit/1ml single-use Carpuject injections, packaged in boxes of 50, under NSN 6505-01-659-1547. All products must strictly adhere to USP standards and comply with the Buy American Act. Key delivery requirements include ensuring a minimum shelf life of 21 months upon receipt. The place of performance is designated as Travis AFB. Interested parties must respond by October 13, 2026, in accordance with the solicitation guidelines for NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

3 days ago

DEADLINE

in 3 days

AI Contract Overview

Solicitation SPE2DP-26-T-4667 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Dextrose 5% Injection, USP, 100 ML, in packages of 80 units. The requirement is identified by NSN 6505-01-384-1362 and specifies a quantity of one package. The product must adhere to United States Pharmacopeia standards and has a non-extendable shelf life of 24 months. Delivery is required within 20 days after receipt of order, with the point of delivery, inspection, and acceptance all set as destination at Fort Bragg, North Carolina. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and requires packaging in accordance with MIL-STD-2073-1E and special instructions MPWM00001. All shipping must utilize suitable commercial exterior containers to ensure safe delivery. Administratively, the contractor must use the Wide Area WorkFlow system for electronic invoicing and payment requests. The solicitation incorporates various FAR and DFARS clauses, including the Buy American Act, safeguarding of covered defense information, and hazardous material labeling standards under 29 CFR 1910.1200. Quotations must be submitted via the DLA Internet Bid Board System.

General Info

DoD procures one 80-unit package of Baxter Dextrose 5% Injection via SPE2DP-26-T-4667.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

BLD A5474 PRATT ST, FORT BRAGG, NC, 28310, USA

Set-Aside

NONE

Documents

Request for Quotations SPE2DP-26-T-4667 Medical Supply Chain

rfq

High

AI Contract Breakdown

Uniform Contract Format

Timeline

1 update

PhaseClosed

PostedAug 17

Solicitation

Deadline changedAug 26

Response deadline changed from Aug 24, 2026 to Aug 28, 2026.

Response DeadlineAug 28

Deadline has passed

Submission Closed

08/28/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUSA

Organization / AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressUSA

Contacts

JAMES MARIANI

contact@example.gov

+1 (555) 000-0000

Full Description

DEXTROSE INJECTION
DEXTROSE 5% INJECTION, USP, 100 ML, 80S
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
BAXTER HEALTHCARE NDC 00338-0551-18
U/I PACKAGE OF 80
95037 MABG JARVIS
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. 1 PG = 80 EA
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a
SPE2DP-26-T-4667
SECTION B
shelf life of 24 months (non-extendable) applies to this item.
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
BAXTER HEALTHCARE CORP IV 04687 P/N 2B0041 BAXTER HEALTHCARE CORPORATION 1G026 P/N NDC00338-0551-18
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017890993 0001 PG 1.000
NSN/MATERIAL:6505013841362
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-384-1362 Quantity: 1 PG Purchase Request: 7017890993QTY: 1 Delivery: 20 days ADO